Blood-based cancer detection
The method is designed to detect changes in blood chemical composition that reveal cancer cells’ molecular fingerprint.
Source: LinkedIn company description · Retrieved October 13, 2026
The company aims to develop, validate and establish a method for molecular fingerprinting of blood samples using ultrafast laser technology.
Its efforts focus primarily on developing diagnostics for breast, lung and prostate cancers.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The method is designed to detect changes in blood chemical composition that reveal cancer cells’ molecular fingerprint.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Snapshot: October 10, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 18, 2026 and October 10, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.